Institute for Vaccine Safety - 2012 Catchup Schedule 4Mo-6Yrs

▼ Vaccine	Min Age for Dose 1	Minimum Interval Between Doses
▼ Vaccine	Min Age for Dose 1	Doses 1 and 2	Doses 2 and 3	Doses 3 and 4	4 and 5
Hepatitis B	Birth	4 wks	8 wks (and 16 wks after dose 1)
Rotavirus¹	6 wks	4 wks	4 wks
Diphtheria, Tetanus, Pertussis²	6 wks	4 wks	4 wks	6 mos	6 mos³
Haemophilus influenzae type b³	6 wks	4 wks if age at dose 1 < 12 mos 8 wks (as final dose) if age at dose 1 at 12-14 mos No further doses needed if age at dose 1 ≥ 15 mos	4 wks if current age < 12 mos 8 wks (as final dose) if current age ≥ 12 mos and dose 2 was given at ≤ 15 mos No further doses needed if age at previous dose ≥ 15 mos	8 wks (as final dose) this dose only necessary for ages 12 - 59 mos if 3 doses were received before 12 mos
Pneumococcal⁴	6 wks	4 wks if age at dose 1 < 12 mos 8 wks (as final dose for healthy children) if dose 1 at ≥ 12 mos or current age = 24-59 mos No further doses needed for healthy children if dose 1 at ≥ 24 mos	4 wks if current age < 12 mos 8 wks (as final dose for healthy children) if current age ≥ 12 mos No further doses needed for healthy children if age at dose 1 ≥ 24 mos	8 wks (as final dose) this dose only necessary for ages 12 - 59 mos if 3 doses were received before 12 mos or for hi-risk children who received 3 doses at any age
Inactivated Poliovirus⁵	6 wks	4 wks	4 wks	6 mos min age 4 yrs for final dose
Meningococcal⁶	12 mos	8 wks
Measles, Mumps, Rubella⁷	12 mos	4 wks
Varicella⁸	12 mos	3 mos
Hepatitis A	12 mos	6 mos

Changes from last schedule

2012 Schedules PDF (adobe acrobat)

2012 Schedule for ages 0-6 years | catch-up schedule

2012 Schedule for ages 7-18 years | catch-up schedule

2012 Schedule for Adults | special

Information about reporting reactions after immunization is available online at www.vaers.hhs.gov or by telephone via the 24-hour national toll-free information line 800-822-7967. Suspected cases of vaccine-preventable diseases should be reported to the state or local health department. Additional information, including precautions and contraindications for immunization, is available from the National Center for Immunization and Respiratory Diseases at www.cdc.gov/vaccines or telephone, 800-CDC-INFO (800-232-4636).

1. Rotavirus vaccine (RV).

The maximum age for the first dose in the series is 14 weeks, 6 days; and 8 months, 0 days for the final dose in the series. Vaccination should not be initiated for infants aged 15 weeks, 0 days or older.
If RV-1 was administered for the first and second doses, a third dose is not indicated.

2. Diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP).

The fifth dose is not necessary if the fourth dose was administered at age 4 years or older.

3. Haemophilus influenzae type b conjugate vaccine (Hib).

Hib vaccine should be considered for unvaccinated persons aged 5 years or older who have sickle cell disease, leukemia, human immunodeficiency virus (HIV) infection, or anatomic/functional asplenia.
If the first 2 doses were PRP-OMP (PedvaxHIB or Comvax), and administered at age 11 months or younger, the third (and final) dose should be administered at age 12 through 15 months and at least 8 weeks after the second dose.
If the first dose was administered at age 7 through 11 months, administer the second dose at least 4 weeks later and a final dose at age 12 through 15 months.

4. Pneumococcal vaccine.(Minimum age: 6 weeks for pneumococcal conjugate vaccine [PCV]; 2 years for pneumococcal polysaccharide vaccine [PPSV])

For children aged 24 through 71 months with underlying medical conditions, administer 1 dose of PCV13 if 3 doses of PCV were received previously or administer 2 doses of PCV13 at least 8 weeks apart if fewer than 3 doses of PCV were received previously.
A single dose of PCV may be administered to certain children aged 6 through 18 years with underlying medical conditions. See age-specific schedules for details.
Administer pneumococcal polysaccharide vaccine (PPSV) to children aged 2 years or older with certain underlying medical conditions. See MMWR 2010;59(No. RR-11).

5. Inactivated poliovirus vaccine (IPV).

A fourth dose is not necessary if the third dose was administered at age 4 years or older and at least 6 months following the previous dose.
In the first 6 months of life, minimum age and minimum intervals are only recommended if the person is at risk for imminent exposure to circulating poliovirus (i.e., travel to a polio-endemic region or during an outbreak).
IPV is not routinely recommended for US residents aged 18 years or older

6. Meningococcal conjugate vaccines, quadrivalent (MCV4). (Minimum age: 9 monthes for Menatctra [MCV4-D]; 2 years for Menveo [MCV4])

See Figure 1 (“Recommended immunization schedule for persons aged 0 through 6 years”) and Figure 2 (“Recommended immunization schedule for persons aged 7 through 18 years”) for further guidance..

7. Measles, mumps, and rubella vaccine (MMR).

Administer the second dose routinely at age 4 through 6 years.

8. Varicella vaccine.

Administer the second dose routinely at age 4 through 6 years.
If the second dose was administered at least 4 weeks after the first dose, it can be accepted as valid.

9. Tetanus and diphtheria toxoids (Td) and tetanus and diphtheria toxoids and acellular pertussis vaccine (Tdap).

For children aged 7 through 10 years who are not fully immunized with the childhood DTaP vaccine series, Tdap vaccine should be substituted for a single dose of Td vaccine in the catch-up series; if additional doses are needed, use Td vaccine. For these children, an adolescent Tdap vaccine dose should not be given.
An inadvertent dose of DTaP vaccine administered to children aged 7 through 10 years can count as part of the catch-up series. This dose can count as the adolescent Tdap dose, or the child can later receive a Tdap booster dose at age 11–12 years.

10. Human papillomavirus vaccine (HPV).

Administer the vaccine series to females (either HPV2 or HPV4) and males (HPV4) at age 13 through 18 years if patient is not previously vaccinated.
Use recommended routine dosing intervals for vaccine series cacth-up; see Figure 2 (“Recommended immunization schedule for persons aged 7 through 18 years”).

This page was last updated on February 08, 2012